Thromb Haemost 1974; 32(01): 124-131
DOI: 10.1055/s-0038-1647679
Original Article
Schattauer GmbH

Electroimmunoassay of Plasma Subunits-A and -S in a Case of Congenital Fibrin Stabilizing Factor Deficiency

T Barbui
1   Division of Haematology, Regional Civil Hospital, Vicenza, Italy
,
G Cartei
1   Division of Haematology, Regional Civil Hospital, Vicenza, Italy
,
T Chisesi
1   Division of Haematology, Regional Civil Hospital, Vicenza, Italy
,
E Dini
1   Division of Haematology, Regional Civil Hospital, Vicenza, Italy
› Author Affiliations
Further Information

Publication History

Received 20 February 1974

Accepted after resubmission 18 April 1974

Publication Date:
24 July 2018 (online)

Summary

Antigenic material related to the fibrin stabilizing factor (Factor XIII-FSF) has been found in all the examined patients with congenital deficiency, albeit in reduced amount.

Recently, Bohn et al. (1973) and Israels et al. (1973) showed that plasma Factor- XIII is composed by two subunits, A (or a) and S (or b); the former active protein, the latter probably FSF-binding protein.

Using specific anti-S and anti-A antisera the Authors found, in a case of congenital deficiency of factor XIII, absence of subunit A. Subunit S presented abnormal behaviour as demonstrated by means of quantitative immunoelectrophoresis according to Laurell.

 
  • References

  • 1 Barbui T, Di Luzio V. 1968; Deficienza congenita del fattore stabilizzante la fibrina (Fattore XIII). Giornale di Clinica Medica 49: 46.
  • 2 Barbui T, Porciello P, Dini E. 1972; Coagulation studies in a case of severe congenital hypofibrinogenemia. Thrombosis et Diathesis Haemorrhagica 28: 129.
  • 3 Bohn H, Haupt H. 1968; Eine quantitative Bestimmung von Faktor XIII mit Anti-Faktor XIII-Serum. Thrombosis et Diathesis Haemorrhagica 19: 309.
  • 4 Bohn H, Haupt H, Kranz T. 1972; Die molekulare Struktur der Fibrin stabilisierenden Faktoren des Menschen. Blut 25: 235.
  • 5 Bohn H, Becker W, Trobish H. 1973; Die molekulare Struktur der Fibrin stabilisierenden Faktoren des Menschen. II Vergleichende immunologische Untersuchungen von Faktor-XIII. Mangelplasmen and normal plasma. Blut 26: 303.
  • 6 Bruhn H. D, Müller L, Duckert F. 1970; Quantitative determination of plasminogen. A caseinolytic method. Thrombosis et Diathesis Haemorrhagica 28: 191.
  • 7 Clarke M. H. G, Freeman H. 1968; Quantitative immunoelectrophoresis of human serum proteins. Clinical Science 35: 403.
  • 8 Duckert F. 1970; Le facteur XIII et la protéine XIII. Nouvelle Revue Française d’Hématologie 10: 685.
  • 9 Duckert F. 1972; Documentation of the plasma factor XIII deficiency in man. Annals of the New York Academy of Sciences 202: 190.
  • 10 Kiesselbach T. H, Wagner R. H. 1966; Fibrin-stabilizing factor: a thrombin labile platelet protein. American Journal Physiology 211: 1472.
  • 11 Israels E. D, Paraskevas F, Israels L. G. 1973; Immunological studies of coagulation factor XIII. The Journal of Clinical Investigation 52: 2398.
  • 12 Loewy A. G, Dunathan K, Kriel R, Wolfinœer Jr H. L. 1961; Fibrinase. I. Purification of substrate and enzyme. Journal Biology and Chemistry 236: 2625.
  • 13 Latjrekl C. B. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45.
  • 14 Milstone A. 1941; A factor in normal human blood, which participates in streptococcal fibrinolysis. Journal of Immunology 42: 109.
  • 15 Quick A. J. 1951. The Physiology and Pathology of haemostasis. Lea and Febiger. Philadelphia.: